Literature DB >> 22885229

pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.

Xue-Qing Wang1, Qiang Zhang.   

Abstract

pH-sensitive polymeric nanoparticles are promising for oral drug delivery, especially for peptide/protein drugs and poorly water-soluble medicines. This review describes current status of pH-sensitive polymeric nanoparticles for oral drug delivery and introduces the mechanisms of drug release from them as well as possible reasons for absorption improvement, with emphasis on our contribution to this field. pH-sensitive polymeric nanoparticles are prepared mainly with polyanions, polycations, their mixtures or cross-linked polymers. The mechanisms of drug release are the result of carriers' dissolution, swelling or both of them at specific pH. The possible reasons for improvement of oral bioavailability include the following: improve drug stability, enhance mucoadhesion, prolong resident time in GI tract, ameliorate intestinal permeability and increase saturation solubility and dissolution rate for poorly water-soluble drugs. As for the advantages of pH-sensitive nanoparticles over conventional nanoparticles, we conclude that (1) most carriers used are enteric-coating materials and their safety has been approved. (2) The rapid dissolution or swelling of carriers at specific pH results in quick drug release and high drug concentration gradient, which is helpful for absorption. (3) At the specific pH carriers dissolve or swell, and the bioadhesion of carriers to mucosa becomes high because nanoparticles turn from solid to gel, which can facilitate drug absorption.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885229     DOI: 10.1016/j.ejpb.2012.07.014

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  25 in total

1.  Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit®S100.

Authors:  Sang Hoon Lee; Seung-Yun Back; Jae Geun Song; Hyo-Kyung Han
Journal:  J Nanobiotechnology       Date:  2020-07-25       Impact factor: 10.435

Review 2.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 3.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

4.  Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.

Authors:  Mohammad Reza Siahi-Shadbad; Saeed Ghanbarzadeh; Mohammad Barzegar-Jalali; Hadi Valizadeh; Alireza Taherpoor; Ghobad Mohammadi; Azim Barzegar-Jalali; Khosro Adibkia
Journal:  Adv Pharm Bull       Date:  2014-08-10

Review 5.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

6.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery.

Authors:  Amrita Banerjee; Jianping Qi; Rohan Gogoi; Jessica Wong; Samir Mitragotri
Journal:  J Control Release       Date:  2016-07-30       Impact factor: 9.776

Review 7.  Stimuli-responsive nanocarriers for intracellular delivery.

Authors:  Lemmuel L Tayo
Journal:  Biophys Rev       Date:  2017-11-25

8.  Probing the modulated formation of gold nanoparticles-beta-lactoglobulin corona complexes and their applications.

Authors:  Jiang Yang; Bo Wang; Youngsang You; Woo-Jin Chang; Ke Tang; Yi-Cheng Wang; Wenzhao Zhang; Feng Ding; Sundaram Gunasekaran
Journal:  Nanoscale       Date:  2017-11-23       Impact factor: 7.790

Review 9.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

Review 10.  pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.

Authors:  Mahdi Karimi; Masoud Eslami; Parham Sahandi-Zangabad; Fereshteh Mirab; Negar Farajisafiloo; Zahra Shafaei; Deepanjan Ghosh; Mahnaz Bozorgomid; Fariba Dashkhaneh; Michael R Hamblin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.